Orthofix Medical, Inc. (OFIX) CEO Jon Serbousek on Q1 2020 Results - Earnings Call Transcript

SA Transcripts
153.96K Followers

Q1: 2020-05-08 Earnings Summary

EPS of $1.32 beats by $1.36
 | Revenue of $104.82M (-3.93% Y/Y) beats by $449.67K

Orthofix Medical Inc. (NASDAQ:OFIX) Q1 2020 Earnings Conference Call May 8, 2020 8:30 AM ET

Company Participants

Mark Quick - Senior Director, Business Development and IR
Jon Serbousek - President and CEO
Doug Rice - CFO

Conference Call Participants

Raj Denhoy - Jefferies
Jeffrey Cohen - Ladenburg Thalmann
Jim Sidoti - Sidoti & Company

Operator

Good morning, ladies and gentlemen, and welcome to the Orthofix First Quarter 2020 Earnings Results Conference Call. [Operator Instructions] As a reminder this conference call is being recorded.

I would now like to turn the conference over to your host Mr. Mark Quick, Senior Director of Business Development and Investor Relations.

Mark Quick

Thank you, operator, and good afternoon, everyone. Welcome to the Orthofix first quarter 2020 earnings call. Joining me on the call today are President and Chief Executive Officer, Jon Serbousek; and Chief Financial Officer, Doug Rice. I'll start with our Safe Harbor statements and then pass it over to Jon.

During this call, we'll be making forward-looking statements that involve risks and uncertainties. All statements, other than those of historical fact, are forward-looking statements, including any earnings guidance we provide, and any updates about our plans, beliefs, strategies, expectations, goals or objectives. Investors are cautioned not to place undue reliance on such forward-looking statements as there is no assurance that the matters contained in such statements will occur.

The forward-looking statements we make on today's call are based on our beliefs and expectations as of today, May 8, 2020. We do not undertake any obligation to revise or update such forward-looking statements. Some factors that could cause actual results to materially different from the forward-looking statements made by us on the call include the risks disclosed under the heading Risk Factors in our Form 10-K for the year ended December 31, 2019, and our Form 10-Q as expected

Recommended For You

About OFIX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on OFIX